Summary

Phototherapy Treatment Market – Scope of Report
TMR’s report on the global phototherapy treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global phototherapy treatment market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global phototherapy treatment market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the phototherapy treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global phototherapy treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global phototherapy treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global phototherapy treatment market.

The report delves into the competitive landscape of the global phototherapy treatment market. Key players operating in the global phototherapy treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global phototherapy treatment market profiled in this report.

Key Questions Answered in Global phototherapy treatment Market Report
• What is the sales/revenue generated by phototherapy treatment across all regions during the forecast period?
• What are the opportunities in the global phototherapy treatment market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Phototherapy Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global phototherapy treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global phototherapy treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global phototherapy treatment market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Phototherapy Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Phototherapy Treatment Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Phototherapy Treatment Market Analysis and Forecast, by Disease Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Disease Type, 2020-2034
6.3.1. Psoriasis
6.3.1.1. Guttate Psoriasis
6.3.1.2. Inverse Psoriasis
6.3.1.3. Pustular Psoriasis
6.3.1.4. Erythrodermic Psoriasis
6.3.1.5. Plaque Psoriasis
6.3.2. Acne
6.3.2.1. Acne Vulgaris
6.3.2.2. Acne Conglobata
6.3.2.3. Acne Fulminans
6.3.2.4. Gram-Negative Folliculitis
6.3.2.5. Acne Rosacea
6.3.2.6. Oyoderma Faciale
6.4. Market Attractiveness Analysis, by Disease Type
7. Global Phototherapy Treatment Market Analysis and Forecast, by Phototherapy Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Phototherapy Type, 2020-2034
7.3.1. Blue Light Phototherapy
7.3.2. Red Light Phototherapy
7.3.3. Intense Pulsed Light (IPL) Phototherapy
7.3.4. Narrowband UVB Phototherapy
7.3.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
7.4. Market Attractiveness Analysis, by Phototherapy Type
8. Global Phototherapy Treatment Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Dermatology Clinics
8.3.3. Homecare Settings
8.3.4. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Phototherapy Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Phototherapy Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Disease Type, 2020-2034
10.3.1. Psoriasis
10.3.1.1. Guttate Psoriasis
10.3.1.2. Inverse Psoriasis
10.3.1.3. Pustular Psoriasis
10.3.1.4. Erythrodermic Psoriasis
10.3.1.5. Plaque Psoriasis
10.3.2. Acne
10.3.2.1. Acne Vulgaris
10.3.2.2. Acne Conglobata
10.3.2.3. Acne Fulminans
10.3.2.4. Gram-Negative Folliculitis
10.3.2.5. Acne Rosacea
10.3.2.6. Oyoderma Faciale
10.4. Market Value Forecast, by Phototherapy Type, 2020-2034
10.4.1. Blue Light Phototherapy
10.4.2. Red Light Phototherapy
10.4.3. Intense Pulsed Light (IPL) Phototherapy
10.4.4. Narrowband UVB Phototherapy
10.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Dermatology Clinics
10.5.3. Homecare Settings
10.5.4. Others (Research Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Disease Type
10.7.2. By Phototherapy Type
10.7.3. By End-user
10.7.4. By Country
11. Europe Phototherapy Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Disease Type, 2020-2034
11.3.1. Psoriasis
11.3.1.1. Guttate Psoriasis
11.3.1.2. Inverse Psoriasis
11.3.1.3. Pustular Psoriasis
11.3.1.4. Erythrodermic Psoriasis
11.3.1.5. Plaque Psoriasis
11.3.2. Acne
11.3.2.1. Acne Vulgaris
11.3.2.2. Acne Conglobata
11.3.2.3. Acne Fulminans
11.3.2.4. Gram-Negative Folliculitis
11.3.2.5. Acne Rosacea
11.3.2.6. Oyoderma Faciale
11.4. Market Value Forecast, by Phototherapy Type, 2020-2034
11.4.1. Blue Light Phototherapy
11.4.2. Red Light Phototherapy
11.4.3. Intense Pulsed Light (IPL) Phototherapy
11.4.4. Narrowband UVB Phototherapy
11.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Dermatology Clinics
11.5.3. Homecare Settings
11.5.4. Others (Research Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Disease Type
11.7.2. By Phototherapy Type
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Phototherapy Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Disease Type, 2020-2034
12.3.1. Psoriasis
12.3.1.1. Guttate Psoriasis
12.3.1.2. Inverse Psoriasis
12.3.1.3. Pustular Psoriasis
12.3.1.4. Erythrodermic Psoriasis
12.3.1.5. Plaque Psoriasis
12.3.2. Acne
12.3.2.1. Acne Vulgaris
12.3.2.2. Acne Conglobata
12.3.2.3. Acne Fulminans
12.3.2.4. Gram-Negative Folliculitis
12.3.2.5. Acne Rosacea
12.3.2.6. Oyoderma Faciale
12.4. Market Value Forecast, by Phototherapy Type, 2020-2034
12.4.1. Blue Light Phototherapy
12.4.2. Red Light Phototherapy
12.4.3. Intense Pulsed Light (IPL) Phototherapy
12.4.4. Narrowband UVB Phototherapy
12.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Dermatology Clinics
12.5.3. Homecare Settings
12.5.4. Others (Research Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Disease Type
12.7.2. By Phototherapy Type
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Phototherapy Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Disease Type, 2020-2034
13.3.1. Psoriasis
13.3.1.1. Guttate Psoriasis
13.3.1.2. Inverse Psoriasis
13.3.1.3. Pustular Psoriasis
13.3.1.4. Erythrodermic Psoriasis
13.3.1.5. Plaque Psoriasis
13.3.2. Acne
13.3.2.1. Acne Vulgaris
13.3.2.2. Acne Conglobata
13.3.2.3. Acne Fulminans
13.3.2.4. Gram-Negative Folliculitis
13.3.2.5. Acne Rosacea
13.3.2.6. Oyoderma Faciale
13.4. Market Value Forecast, by Phototherapy Type, 2020-2034
13.4.1. Blue Light Phototherapy
13.4.2. Red Light Phototherapy
13.4.3. Intense Pulsed Light (IPL) Phototherapy
13.4.4. Narrowband UVB Phototherapy
13.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Dermatology Clinics
13.5.3. Homecare Settings
13.5.4. Others (Research Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Disease Type
13.7.2. By Phototherapy Type
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Phototherapy Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Disease Type, 2020-2034
14.3.1. Psoriasis
14.3.1.1. Guttate Psoriasis
14.3.1.2. Inverse Psoriasis
14.3.1.3. Pustular Psoriasis
14.3.1.4. Erythrodermic Psoriasis
14.3.1.5. Plaque Psoriasis
14.3.2. Acne
14.3.2.1. Acne Vulgaris
14.3.2.2. Acne Conglobata
14.3.2.3. Acne Fulminans
14.3.2.4. Gram-Negative Folliculitis
14.3.2.5. Acne Rosacea
14.3.2.6. Oyoderma Faciale
14.4. Market Value Forecast, by Phototherapy Type, 2020-2034
14.4.1. Blue Light Phototherapy
14.4.2. Red Light Phototherapy
14.4.3. Intense Pulsed Light (IPL) Phototherapy
14.4.4. Narrowband UVB Phototherapy
14.4.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Dermatology Clinics
14.5.3. Homecare Settings
14.5.4. Others (Research Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Disease Type
14.7.2. By Phototherapy Type
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Lifespan Health System
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. UCI Health
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Buffalo Medical Group
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Blackrock Health
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. The Private Phototherapy Clinic Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. High Risk Skin Centre Clinic Massachusetts General Hospital
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Signify Holding
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. GE Healthcare
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Natus Medical Incorporated
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview